Pinnacle Private Wealth’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$322K Buy
30,445
+400
+1% +$4.23K 0.13% 185
2022
Q1
$489K Hold
30,045
0.15% 155
2021
Q4
$416K Buy
+30,045
New +$416K 0.13% 170